A novel therapeutic multiepitope vaccine based on oncoprotein E6 and E7 of HPV 16 and 18: An in silico approach

Sari Eka Pratiwi ¹ * , Ysrafil Ysrafil ² , Mardhia Mardhia ³ , Mahyarudin Mahyarudin ³ , Muhammad Inam Ilmiawan ¹, Heru Fajar Trianto ^1,4, Delima Fajar Liana ³, Yuri Amia ⁵

Cited by CrossRef: 0

1- Ansarova S, Basalova J, Heydarova A, Grineva A, Obukhova E, Romanenko M, Raevskii K. Prevention of human papillomavirus-associated cervical disease in the 21st century. Russian Medicine. 2025;31(3):279 [Crossref]

2- Naully P, Tan M, El Khobar K, Sukowati C, Giri-Rachman E. Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics. World J Hepatol. 2025;17(7) [Crossref]

3- Sadeghi Z, Aboofazeli A, Sarrafzadeh S, Tayebi N, Tajdini R, Yarandi F, Jazayeri S. Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centre. Virol J. 2025;22(1) [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of
Follower of ICMJE
Permission: Creative Commons